# Title

 Food and Drugs. PART 1304â€”RECORDS AND REPORTS OF REGISTRANTS


# ID

 CFR-2018-title21-vol9.Pt. 1304


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['exceeds', 'more than', 'no later than', 'before', 'after', 'prior to', 'less than', 'at least', 'within', 'no less than', 'later than']                                                                                                                                                                                                                                                                                                           |
| Duration    | ['30 day', '2.0 year', '15 day', '2 year', '14.0 day', '30.0 day', '2 day']                                                                                                                                                                                                                                                                                                                                                                         |
| Condition   | ['subject to', 'when', 'if', 'unless', 'where']                                                                                                                                                                                                                                                                                                                                                                                                     |
| Entities    | ['Import', 'Assay', 'Scope', 'Benzphetamine', 'Charge', 'Cyclobarbital', 'Schedules II', 'Food', 'Barbital', 'Schedules III', 'U.S. Pharmacopoeia', 'Methyprylon', 'Schedule III', 'Approval', 'Lefetamine', 'United States', 'U.S. Pharmacopeia', 'Schedules III and IV', 'Additional', 'Phenobarbital', 'Inventory', 'U.S.P., N.F', 'Meprobamate', 'Phentermine', 'Written', 'Schedule V', 'Ethchlorvynol', 'Mazindol', 'Request', 'Maintenance'] |
| Date        | ['2018-12-31', '2009-04-13', '2009-05-13', '2018-01-15', '1980-09-30']                                                                                                                                                                                                                                                                                                                                                                              |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                   |
|:--------------|:--------------------------------------------------------------------------------------------------------------------------|
| at least      | kept by the registrant and be available, for at least 2 years from the date of such inventory                             |
| after         | registrant may maintain central records commencing 14 days after receipt of his notification by the Special Agent         |
| within        | part of such records to the registered location within two business days upon receipt of a written                        |
| within        | recordkeeping authorizations under this paragraph the registrant shall, within the time specified by the Special Agent in |
| no less than  | the lower right corner with the letter &#8220;C&#8221; no less than 1 inch high and filed either in the                   |
| at least      | of all stocks of controlled substances on hand at least  every two years.                                                 |
| within        | may be taken on any date which is within  two years of the previous biennial inventory date.                              |
| prior to      | schedule of controlled substances, which substance was, immediately prior to that date, not listed on any such schedule,  |
| after         | There after , such substance shall be included in each                                                                    |
| more than     | measure of the contents, unless the container holds more than 1,000 tablets or capsules in which case an                  |
| less than     | If  less than 1 kilogram of any controlled substance (other than                                                          |
| less than     | If  less than 1 kilogram of any controlled substance (other than                                                          |
| less than     | If  less than 1 kilogram of any controlled substance (other than                                                          |
| more than     | measure of the contents, unless the container holds more than 1,000 tablets or capsules in which case he/she              |
| after         | substance remains in a vial, tube, or syringe after administration but cannot or may not be further                       |
| more than     | measure of the contents, unless the container holds more than 1,000 tablets or capsules in which case an                  |
| before        | and Quota Section, Diversion Control Division, on or before the 15th day of the month immediately following               |
| before        | and Quota Section, Diversion Control Division, on or before the 15th day of the month immediately following               |
| later than    | transaction reports shall be filed every quarter not later than the 15th day of the month succeeding the                  |
| later than    | These reports shall be filed not  later than  January 15 of the following year.                                           |
| later than    | be filed annually for each calendar year not later than January 15 of the following year, except that                     |
| prior to      | (a) Thirty days  prior to offering a controlled substance for sale, delivery, distribution,                               |
| at least      | of any change in any such Internet address at least  30 days in advance.                                                  |
| more than     | orders made on, through, or on behalf of, more than one Web site, the pharmacy shall provide, for                         |
| before        | the notifications required in this section on or before  May 13, 2009.                                                    |
| after         | (d) On and  after the date an online pharmacy makes the notifications                                                     |
| after         | (d) On and  after the date an online pharmacy makes the notifications                                                     |
| no later than | shall notify the Administrator of the updated information no later than 30 days before the change becomes effective via   |
| before        | the updated information no later than 30 days before  the change becomes effective via the online process.                |
| no later than | section, the online pharmacy shall notify the Administrator no later than 30 days after the change becomes effective via  |
| after         | notify the Administrator no later than 30 days after  the change becomes effective via the online process.                |
| no later than | pharmacy, the online pharmacy shall notify the Administrator no later than 30 days after the change becomes effective via |
| after         | notify the Administrator no later than 30 days after  the change becomes effective via the online process.                |
| at least      | This includes  at least one prior in-person medical evaluation in accordance with                                         |
| exceeds       | controlled substances dispensed by the pharmacy meets or exceeds one of the following thresholds: (1) 100 or              |
| later than    | (e) Reports shall be filed every month not  later than the fifteenth day of the month succeeding the                      |
| at least      | section must be kept by the registrant for at least  two years from the date of such records.                             |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2 year     | Similarly, the researcher may store all of his controlled items in one place, and every two years take inventory of all items on hand, regardless of whether the substances were manufactured by him, imported by him, or purchased domestically by him, of whether the substances will be administered to subjects, distributed to other researchers, or destroyed during chemical analysis.                                                                                               |
| 2 year     | These records must be maintained for a period of two years.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 2.0 year   | (a) Except as provided in paragraphs (a)(1) and (a)(2) of this section, every inventory and other records required to be kept under this part must be kept by the registrant and be available, for at least 2 years from the date of such inventory or records, for inspection and copying by authorized employees of the Administration.                                                                                                                                                   |
| 14.0 day   | Unless the registrant is informed by the Special Agent in Charge that permission to keep central records is denied, the registrant may maintain central records commencing 14 days after receipt of his notification by the Special Agent in Charge.                                                                                                                                                                                                                                        |
| 2 day      | (3) The registrant agrees to deliver all or any part of such records to the registered location within two business days upon receipt of a written request from the Administration for such records, and if the Administration chooses to do so in lieu of requiring delivery of such records to the registered location, to allow authorized employees of the Administration to inspect such records at the central location upon request by such employees without a warrant of any kind. |
| 2 year     | (g) Unless otherwise specified, records and reports must be retained for two years.                                                                                                                                                                                                                                                                                                                                                                                                         |
| 2 year     | After the initial inventory is taken, the registrant shall take a new inventory of all stocks of controlled substances on hand at least every two years.                                                                                                                                                                                                                                                                                                                                    |
| 2 year     | The biennial inventory may be taken on any date which is within two years of the previous biennial inventory date.                                                                                                                                                                                                                                                                                                                                                                          |
| 30 day     | (a) Thirty days prior to offering a controlled substance for sale, delivery, distribution, or dispensing by means of the Internet, an online pharmacy shall:                                                                                                                                                                                                                                                                                                                                |
|            |             (1) Notify the Administrator of its intent to do so by submitting an application for a modified registration in accordance with &#167;&#167;&#8201;1301.13 and 1301.19 of this chapter, with such application containing the information required by this section; and                                                                                                                                                                                                          |
|            |             (2) Notify the State boards of pharmacy in any States in which the online pharmacy offers to sell, deliver, distribute, or dispense controlled substances.                                                                                                                                                                                                                                                                                                                      |
| 30.0 day   | The statement shall be in a form similar to the following: &#8220;The above-named pharmacy, a DEA registrant, certifies, under penalty of perjury, that the information contained in this statement is true and accurate.&#8221;                                                                                                                                                                                                                                                            |
|            |             (3) Each Internet site address utilized by the online pharmacy and a certification that the online pharmacy shall notify the Administrator of any change in any such Internet address at least 30 days in advance.                                                                                                                                                                                                                                                              |
| 30.0 day   | (d) On and after the date an online pharmacy makes the notifications required under this section, each online pharmacy shall display on the homepage of its Internet site, a declaration that it has made such notifications to the Administrator in the following form: &#8220;In accordance with the Controlled Substances Act and the DEA regulations, this online pharmacy has made the notifications to the DEA Administrator required by 21 U.S.C. 831 and 21 CFR 1304.40.&#8221;     |
|            |             (e)(1) Except as provided in paragraphs (e)(2) and (e)(3) of this section, if any of the information required to be submitted under this section changes after the online pharmacy submits the notification to the Administrator, the online pharmacy shall notify the Administrator of the updated information no later than 30 days before the change becomes effective via the online process.                                                                               |
| 30.0 day   | (2) If a pharmacy referred to in paragraph (b)(4)(i) of this section ceases to deliver, distribute, or dispense controlled substances pursuant to orders made on, through, or on behalf of, each Web site referred to in paragraph (b)(3) of this section, the online pharmacy shall notify the Administrator no later than 30 days after the change becomes effective via the online process.                                                                                              |
| 30.0 day   | (3) If a practitioner referred to in paragraph (b)(4)(ii) of this section ceases to have a contractual relationship with the online pharmacy, the online pharmacy shall notify the Administrator no later than 30 days after the change becomes effective via the online process.                                                                                                                                                                                                           |
| 15 day     | (e) Reports shall be filed every month not later than the fifteenth day of the month succeeding the month for which they are submitted.                                                                                                                                                                                                                                                                                                                                                     |
| 2 year     | (g) Records required to be kept under this section must be kept by the registrant for at least two years from the date of such records.                                                                                                                                                                                                                                                                                                                                                     |


## Condition

| Condition   | Context                                                                                                                                     |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------------------|
| when        | Thus,  when a researcher manufactures a controlled item, he must                                                                            |
| when        | Thus,  when a researcher manufactures a controlled item, he must                                                                            |
| when        | Thus,  when a researcher manufactures a controlled item, he must                                                                            |
| when        | Thus,  when a researcher manufactures a controlled item, he must                                                                            |
| unless      | prescribed in the lawful course of professional practice, unless such substances are prescribed in the course of                            |
| unless      | administered in the lawful course of professional practice unless the practitioner regularly engages in the dispensing or                   |
| if          | those sections, are not required to keep records if  he/she not                                                                             |
| if          | keep the records and file the reports spec if ied in &#167;&#8201;1304.06 and part 1311 of this                                             |
| subject to  | and packing slips but not executed order forms subject to &#167;&#167;&#8201;1305.17 and 1305.27 of this chapter) may be                    |
| if          | central location, rather than at the registered location, if  the registrant has not                                                        |
| where       | (ii) The exact location  where  the records will be kept.                                                                                   |
| subject to  | under paragraph (a) of this section shall be subject to the following conditions: (1) The records to be                                     |
| if          | provide access to such equipment with the records. if                                                                                       |
| if          | request from the Administration for such records, and if the Administration chooses to do so in lieu                                        |
| if          | Prescriptions will be deemed readily retrievable  if , at the time they are initially filed,                                                |
| if          | However,  if a pharmacy employs a computer application for prescriptions                                                                    |
| if          | must be readily retrievable at the registered location if requested by the Administration or other law enforcement                          |
| where       | proofing and issuance of the two-factor authentication credential, where  applicable, as required by &#167;&#8201;1311.110 of this chapter. |
| unless      | and reports must be retained for two years. unless                                                                                          |
| if          | substances shall be deemed to be &#8220;on hand&#8221; if they are in the possession of or under                                            |
| subject to  | of the registered location to which they are subject to control or to which the person possessing the                                       |
| if          | in each batch and/or stage of manufacture, ident if ied by the batch number or other appropriate                                            |
| if          | exact count or measure of the contents; or if the substance is listed in Schedule III, IV,                                                  |
| if          | exact count or measure of the contents; or if the substance is listed in Schedule III, IV,                                                  |
| unless      | an estimated count or measure of the contents, unless the container holds more than 1,000 tablets or                                        |
| if          | must make an exact count of the contents. if                                                                                                |
| if          | must make an exact count of the contents. if                                                                                                |
| unless      | an estimated count or measure of the contents, unless the container holds more than 1,000 tablets or                                        |
| subject to  | of the registered location to which they are subject to control or to which the person possessing the                                       |
| when        | for immediate administration at the practitioner's registered location, when the substance is not fully exhausted (e.g., some               |
| if          | the date, quantity and batch or other ident if ying number of each batch manufactured; (iii) The                                            |
| if          | (A) The date and batch or other ident if ying number of each manufacture; (B) The operation                                                 |
| if          | exact count or measure of the contents; or if the substance is listed in Schedule III, IV,                                                  |
| if          | exact count or measure of the contents; or if the substance is listed in Schedule III, IV,                                                  |
| unless      | an estimated count or measure of the contents, unless the container holds more than 1,000 tablets or                                        |
| where       | liner is installed, the address of the location where each inner liner is installed, the unique identification                              |
| if          | manufacture and the name, address, and registration number, if any, of the person from whom the substance                                   |
| if          | manufacture and the name, address, and registration number, if any, of the person from whom the substance                                   |
| if          | the date, quantity and batch or other ident if ying number of each batch compounded; (3) The                                                |
| if          | (i) The date and batch or other ident if ying number of each compounding; (ii) The operation                                                |
| if          | (e) Patient's insurance provider,  if  available.                                                                                           |
| subject to  | on the basis of the best data available, subject to adjustment, and the necessary adjusting entries shall be                                |
| where       | kept a complete record of all withdrawals therefrom. where                                                                                  |
| subject to  | on the basis of the best data available, subject to adjustment, and the necessary adjusting entries shall be                                |
| where       | be kept a complete record of withdrawals therefrom. where                                                                                   |
| if          | presented in such a manner as to ident if y the particular form, strength, and trade name,                                                  |
| unless      | a controlled substance by means of the Internet unless such online pharmacy is validly registered with a                                    |
| if          | the date an online pharmacy makes the not if ications required under this section, each online pharmacy                                     |
| if          | of this section, the online pharmacy shall not if y the Administrator no later than 30 days                                                 |
| if          | the online pharmacy, the online pharmacy shall not if y the Administrator no later than 30 days                                             |
| if          | deemed to meet the requirements of this section if , in lieu of posting the names of                                                        |
| if          | Each online pharmacy shall report a negative response if , during a given calendar month, its total                                         |


## Entities

| Entities             | Context                                                                                                                                                |
|:---------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                 | Food  and Drugs.                                                                                                                                       |
| Scope                | Scope  of part 1304.                                                                                                                                   |
| Inventory            | Inventory and other records and reports required under section                                                                                         |
| Schedules II         | as described in &#167;&#8201;1304.04, of controlled substances in Schedules II , III, IV, and V which are dispensed,                                   |
| Schedules II         | required to keep records of controlled substances in Schedules II , III, IV, and V that are prescribed                                                 |
| Schedules II         | to keep records of controlled substances listed in Schedules II , III, IV and V which are administered                                                 |
| Approval             | Approval of the request to maintain central records would                                                                                              |
| Maintenance          | Maintenance  of records and inventories.                                                                                                               |
| Written              | Written notification must be submitted by registered or certified                                                                                      |
| Charge               | registrant is informed by the Special Agent in Charge that permission to keep central records is denied,                                               |
| Charge               | registrant is informed by the Special Agent in Charge that permission to keep central records is denied,                                               |
| Charge               | comply with these conditions, the Special Agent in Charge may cancel such central recordkeeping authorization, and all                                 |
| Charge               | the time specified by the Special Agent in Charge , comply with the requirements of this section                                                       |
| Charge               | Registrants need not notify the Special Agent in Charge or obtain central recordkeeping approval in order to                                           |
| Request              | Request for central reporting identifiers will be submitted to                                                                                         |
| Schedules III        | Inventories and records of controlled substances listed in Schedules III , IV, and V shall be maintained either                                        |
| Inventory            | Inventory  requirements.                                                                                                                               |
| Schedule III         | contents; or if the substance is listed in Schedule III , IV, or V, make an estimated count                                                            |
| Schedule III         | or (ii) If the substance is listed in Schedule III , IV, or V, make an estimated count                                                                 |
| Schedule III         | contents; or if the substance is listed in Schedule III , IV, or V, make an estimated count                                                            |
| U.S.P., N.F          | of the substance in such form (e.g., C.P., U.S.P., N.F ., 10-milligram tablet or 10-milligram concentration per milliliter);                           |
| Additional           | Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric                                                      |
| U.S. Pharmacopeia    | finished marketable products, standardized in accordance with the U.S. Pharmacopeia , National Formulary or other recognized medical standards.        |
| Import               | for importation of each narcotic raw material: (1) Import permit number; (2) Date shipment arrived at the                                              |
| United States        | permit number; (2) Date shipment arrived at the United States port of entry; (3) Actual quantity shipped; (4)                                          |
| Assay                | port of entry; (3) Actual quantity shipped; (4) Assay (percent) of morphine, codeine and thebaine and (5)                                              |
| U.S. Pharmacopoeia   | and according to the method specified in the U.S. Pharmacopoeia .                                                                                      |
| U.S. Pharmacopoeia   | bulk or finished products standardized in accordance with U.S. Pharmacopoeia , National Formulary, or other recognized standards.                      |
| Import               | be submitted for importation of coca leaves: (1) Import permit number; (2) Date the shipment arrived at                                                |
| United States        | number; (2) Date the shipment arrived at the United States port of entry; (3) Actual quantity shipped; (4)                                             |
| Assay                | port of entry; (3) Actual quantity shipped; (4) Assay (percent) of cocaine alkaloid and (5) Total cocaine                                              |
| Schedule III         | in Schedules I, II, narcotic controlled substances in Schedule III , and gamma-hydroxybutyric acid drug product controlled substances                  |
| Schedule III         | in Schedules I, II, narcotic controlled substances in Schedule III , and gamma-hydroxybutyric acid drug product controlled substances                  |
| Schedules III        | and II, each narcotic controlled substance listed in Schedules III , IV, and V, gamma-hydroxybutyric acid drug product                                 |
| Schedule III         | V, gamma-hydroxybutyric acid drug product controlled substances in Schedule III , and on each psychotropic controlled substance listed                 |
| Schedules III and IV | and on each psychotropic controlled substance listed in Schedules III and IV  as identified in paragraph (d) of this section.                          |
| Schedule III         | II, on each narcotic controlled substance listed in Schedule III (but not on any material, compound, mixture or                                        |
| Schedule III         | II, on each narcotic controlled substance listed in Schedule III (but not on any material, compound, mixture or                                        |
| Schedule V           | or on any narcotic controlled substance listed in Schedule V ), and on gamma-hydroxybutyric acid drug products listed                                  |
| Schedule III         | II, on each narcotic controlled substance listed in Schedule III (but not on any material, compound, mixture or                                        |
| Schedules III and IV | include the following psychotropic controlled substances listed in Schedules III and IV : (i) Schedule III (A) Benzphetamine; (B) Cyclobarbital;       |
| Benzphetamine        | Schedules III and IV: (i) Schedule III (A) Benzphetamine ;                                                                                             |
|                      |             (B) Cyclobarbital;                                                                                                                         |
|                      |             (C) Methyprylon; and                                                                                                                       |
|                      |             (D) Phendimetrazine.                                                                                                                       |
| Cyclobarbital        | and IV: (i) Schedule III (A) Benzphetamine; (B) Cyclobarbital ;                                                                                        |
|                      |             (C) Methyprylon; and                                                                                                                       |
|                      |             (D) Phendimetrazine.                                                                                                                       |
| Methyprylon          | (i) Schedule III (A) Benzphetamine; (B) Cyclobarbital; (C) Methyprylon ; and                                                                           |
|                      |             (D) Phendimetrazine.                                                                                                                       |
| Barbital             | (ii) Schedule IV                                                                                                                                       |
|                      |             (A)  Barbital ; (B) Diethylpropion (Amfepramone); (C) Ethchlorvynol; (D) Ethinamate;                                                       |
| Ethchlorvynol        | Schedule IV (A) Barbital; (B) Diethylpropion (Amfepramone); (C) Ethchlorvynol ; (D) Ethinamate; (E) Lefetamine (SPA); (F) Mazindol;                    |
| Lefetamine           | (B) Diethylpropion (Amfepramone); (C) Ethchlorvynol; (D) Ethinamate; (E) Lefetamine (SPA); (F) Mazindol; (G) Meprobamate; (H) Methylphenobarbital; (I) |
| Mazindol             | (C) Ethchlorvynol; (D) Ethinamate; (E) Lefetamine (SPA); (F) Mazindol ; (G) Meprobamate; (H) Methylphenobarbital; (I) Phenobarbital; (J)               |
| Meprobamate          | (D) Ethinamate; (E) Lefetamine (SPA); (F) Mazindol; (G) Meprobamate ; (H) Methylphenobarbital; (I) Phenobarbital; (J) Phentermine; and                 |
| Phenobarbital        | (SPA); (F) Mazindol; (G) Meprobamate; (H) Methylphenobarbital; (I) Phenobarbital ;                                                                     |
|                      |             (J) Phentermine; and                                                                                                                       |
|                      |             (K) Pipradrol.                                                                                                                             |
| Phentermine          | Mazindol; (G) Meprobamate; (H) Methylphenobarbital; (I) Phenobarbital; (J) Phentermine ; and                                                           |
|                      |             (K) Pipradrol.                                                                                                                             |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                          |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1980-09-30 | (e) All central recordkeeping permits previously issued by the Administration expired September 30, 1980.                                                                                                                                                                                                                                        |
| 2018-12-31 | Inventories shall provide data on the stocks of each reported controlled substance on hand as of the close of business on December 31 of each year, indicating whether the substance is in storage or in process of manufacturing.                                                                                                               |
| 2018-01-15 | These reports shall be filed not later than January 15 of the following year.                                                                                                                                                                                                                                                                    |
| 2018-01-15 | Manufacturing transaction reports shall be filed annually for each calendar year not later than January 15 of the following year, except that a registrant may be given permission to file more frequently (but not more frequently than quarterly).                                                                                             |
| 2009-04-13 | (c) An online pharmacy that is in operation at the time Public Law 110-425 becomes effective (April 13, 2009) must make the notifications required in this section on or before May 13, 2009.                                                                                                                                                    |
| 2009-05-13 | (c) An online pharmacy that is in operation at the time Public Law 110-425 becomes effective (April 13, 2009) must make the notifications required in this section on or before May 13, 2009.                                                                                                                                                    |
| 2009-04-13 | However, in accordance with section 401(h) of the Act (21 U.S.C. 841(h)), as of April 13, 2009, it is unlawful for any online pharmacy to deliver, distribute, or dispense a controlled substance by means of the Internet unless such online pharmacy is validly registered with a modification of such registration authorizing such activity. |


